Afton Chemical Completes Multimillion Dollar Expansion of Japan Technology Center in Tsukuba
30.10.2019 09:00:00 EET | Business Wire | Press release
Afton Chemical Corporation, a global leader in the lubricant and fuel additive market, announced the completion of its Japan Technology Center expansion in Tsukuba. Mr. Jon Heese, City Councilor for Tsukuba, jointly opened the Japan Technology Center with Mr. Teddy Gottwald, Chairman and CEO of NewMarket Corporation and Mrs. Regina A. Harm, President of Afton Chemical Corporation, subsidiary of NewMarket.
The investment provides an expansion of the analytical and mechanical laboratories to increase lubricant additive testing capabilities. This includes standardized and bespoke tests for transmission fluids, gear lubricants, passenger cars, motorcycles, commercial and off-road vehicles engine oils as well as industrial hydraulic oils. The expanded facility will provide its customers with enhanced technical services such as sample blending, physical/chemical analysis and performance testing that comply with international and Japan unique test methods like ASTM, JIS, JPI, JASO and JCMAS.
“We are committed to bringing our Passion for Solutions® model to Japan and the Asia-Pacific region to help our customers differentiate their offerings to meet the needs of the local marketplace. The expanded Japan Technology Center with its integrated technical support and performance testing will further enhance our ability to provide quick and effective solutions to our customers in Asia, and will provide customized solutions 'Made For' key Japan OEM projects,” said Mrs. Regina A. Harm, President of Afton Chemical Corporation.
“Afton Japan is a unique market with different needs and challenges. The 'Made For' strategy is built on the intent to understand the dynamics of each individual market and ensure we are developing the correct solutions from a product and services perspective. We constantly keep track of the local and global trends impacting the market and partner our customers to develop innovative additive solutions that exceed industry standards,” said Mr. Sean Spencer, Vice President and Managing Director of Afton Chemical Asia.
The expanded capabilities of the Japan Technology Center, with its integrated technical support, will enhance our capability to help customers:
- perform validation tests that comply with OEM, industry standards and specifications
- develop Afton proprietary tests that focus on the needs of Asia Pacific
- support and deliver their differentiated product performance claims promptly
With the Japanese government’s recent announcement further reducing the average vehicle fuel economy standards by 32% by 2030, Japanese automobile manufacturers will have to sell more electric and hybrid cars. “EV and Hybrid vehicles are equipped with transmission like CVT, one-shift ATF as well as gear and bearing to transfer and assist motor torque to wheels. Ultra-low viscosity oil is one of the solutions to lower fuel economy. Afton is working proactively with key OEMs worldwide to develop the technology and lubricant needs for electric/hybrid vehicles. Afton is ready and will have the most advanced additives to meet these new requirements. Our additives will continue to help the automotive industry reduce emissions, improve fuel economy, and extend the useful life of fluids and equipment,” said Togawa Takayuki, R&D Group Lead.
The Japan Technology Center’s state-of-the-art chemistry and mechanical laboratories operate with lean processes and tests run are in full compliance with ISO 9001/14001 safety, environmental and quality standards. The state-of-the-art facility houses a team of 17 R&D managers, formulators, technologists, technician and administration staff, increasing the workforce by 100% since the last decade.
Afton has an extensive network of research and development and testing facilities in the United States, China, India, Japan and the United Kingdom. At these facilities, testing is conducted to ensure products meet or exceed the latest performance requirements of both OEM and industry specifications. Proprietary tests are developed and field trials are designed to create compelling proof of performance data that helps our customers’ products stand out in their markets.
About Afton Chemical Corporation:
Afton Chemical Corporation is part of the NewMarket Corporation (NYSE: NEU) family of companies. Afton Chemical Corporation uses its formulation, engineering and marketing expertise to help their customers develop and market fuels and lubricants that reduce emissions, improve fuel economy, extend equipment life, improve operator satisfaction and lower the total cost of vehicle and equipment operation. Afton Chemical Corporation develops and sells an extensive line of unique additives for gasoline and distillate fuels, driveline fluids, engine oils and industrial lubricants. Afton Chemical Corporation supports global operations through regional headquarters located in Asia Pacific, EMEAI, Latin America and North America. Afton Chemical Corporation is headquartered in Richmond, Virginia. For more information, visit www.aftonchemical.com.
Cautionary Note Regarding Forward-Looking Statements:
Some of the information contained in this press release constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although NewMarket’s management believes its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that actual results will not differ materially from expectations.
Factors that could cause actual results to differ materially from expectations include, but are not limited to, the availability of raw materials and distribution systems; disruptions at production facilities, including single-sourced facilities; hazards common to chemical businesses; the ability to respond effectively to technological changes in our industry; failure to protect our intellectual property rights; sudden or sharp raw material price increases; competition from other manufacturers; the gain or loss of significant customers; current and future governmental regulations; failure to attract and retain a highly-qualified workforce; the occurrence or threat of extraordinary events, including natural disasters and terrorist attacks; risks related to operating outside of the United States; the impact of substantial indebtedness on our operational and financial flexibility; the impact of fluctuations in foreign exchange rates; an information technology system failure or security breach; resolution of environmental liabilities or legal proceedings; political, economic, and regulatory factors concerning our products; limitation of our insurance coverage; our inability to realize expected benefits from investment in our infrastructure or from recent or future acquisitions, or our inability to successfully integrate recent or future acquisitions into our business; the underperformance of our pension assets resulting in additional cash contributions to our pension plans; and other factors detailed from time to time in the reports that NewMarket files with the Securities and Exchange Commission, including the risk factors in Item 1A. “Risk Factors” of our 2018 Annual Report on Form 10-K, which is available to shareholders upon request.
You should keep in mind that any forward-looking statement made by NewMarket in the foregoing discussion speaks only as of the date on which such forward-looking statement is made. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect the Company. We have no duty to, and do not intend to, update or revise the forward-looking statements in this discussion after the date hereof, except as may be required by law. In light of these risks and uncertainties, you should keep in mind that the events described in any forward-looking statement made in this discussion, or elsewhere, might not occur.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005992/en/
Contact information
AP: Chong Kit Lee on +65 6739 6330 or KitLee.Chong@AftonChemical.com
EMEAI: Kate Edrupt on +44 1344 356823 or Kate.Edrupt@AftonChemical.com
NA: Lauren Packard on +1 804 788 6081 or Lauren.Packard@AftonChemical.com
JAPAN: Kyodo PR on +81-(0)3-3571-5258 or afton-pr@kyodo-pr.co.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 18:08:00 EEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
